Literature DB >> 24829390

Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".

Teysir Halaby1, Nashwan Al Naiemi2, Christina M J E Vandenbroucke-Grauls3.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24829390      PMCID： PMC4068485          DOI： 10.1128/AAC.02814-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  27 in total

1.  Extended-spectrum beta-lactamases: a call for improved detection and control.

Authors:  D L Paterson; V L Yu
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit.

Authors:  D L Paterson; N Singh; J D Rihs; C Squier; B L Rihs; R R Muder
Journal:  Clin Infect Dis       Date:  2001-05-23       Impact factor: 9.079

Review 3.  Selective digestive decontamination should not be routinely employed.

Authors:  Marin H Kollef
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

4.  Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.

Authors:  M P Hazenberg; M Van de Boom; M Bakker; J P Van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

5.  Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract.

Authors:  E M Veringa; D van der Waaij
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

6.  Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients.

Authors:  Marc Leone; Jacques Albanese; François Antonini; Annie Nguyen-Michel; Claude Martin
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

7.  Interaction of sucralfate with antibiotics used for selective decontamination of the gastrointestinal tract.

Authors:  B Feron; C G Adair; S P Gorman; B McClurg
Journal:  Am J Hosp Pharm       Date:  1993-12

8.  Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance.

Authors:  H K van Saene; C P Stoutenbeek; D F Zandstra
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.

Authors:  C Brun-Buisson; P Legrand; A Rauss; C Richard; F Montravers; M Besbes; J L Meakins; C J Soussy; F Lemaire
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

10.  Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment.

Authors:  Evan S Snitkin; Adrian M Zelazny; Jyoti Gupta; Tara N Palmore; Patrick R Murray; Julia A Segre
Journal:  Genome Res       Date:  2013-04-05       Impact factor: 9.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.